CURRENT STATUS OF CLINICAL-TRIALS OF THERAPEUTIC MODALITIES FOR MALIGNANT-MELANOMA IN AUSTRALIA

被引:1
作者
COATES, A
机构
[1] UNIV SYDNEY,SYDNEY MELANOMA UNIT,SYDNEY,NSW 2006,AUSTRALIA
[2] UNIV SYDNEY,LUDWIG INST CANC RES,SYDNEY BRANCH,SYDNEY,NSW 2006,AUSTRALIA
来源
PIGMENT CELL RESEARCH | 1989年 / 2卷 / 04期
关键词
D O I
10.1111/j.1600-0749.1989.tb00223.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:370 / 371
页数:2
相关论文
共 9 条
[1]   ON THE RECEIVING END .2. LINEAR ANALOG SELF-ASSESSMENT (LASA) IN EVALUATION OF ASPECTS OF THE QUALITY OF LIFE OF CANCER-PATIENTS RECEIVING THERAPY [J].
COATES, A ;
DILLENBECK, CF ;
MCNEIL, DR ;
KAYE, SB ;
SIMS, K ;
FOX, RM ;
WOODS, RL ;
MILTON, GW ;
SOLOMON, J ;
TATTERSALL, MHN .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (11) :1633-1637
[2]   ON THE RECEIVING END PATIENT PERCEPTION OF THE SIDE-EFFECTS OF CANCER-CHEMOTHERAPY [J].
COATES, A ;
ABRAHAM, S ;
KAYE, SB ;
SOWERBUTTS, T ;
FREWIN, C ;
FOX, RM ;
TATTERSALL, MHN .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (02) :203-208
[3]   PHASE-II STUDY OF RECOMBINANT INTERFERON-ALPHA-2 IN ADVANCED MALIGNANT-MELANOMA [J].
COATES, A ;
RALLINGS, M ;
HERSEY, P ;
SWANSON, C .
JOURNAL OF INTERFERON RESEARCH, 1986, 6 (01) :1-4
[4]  
Coates A. S., 1984, MALIGNANT MELANOMA, P275
[5]   CHEMOTHERAPY IN METASTATIC MELANOMA - PHASE-II STUDIES OF AMSACRINE, MITOXANTRONE AND BISANTRENE [J].
COATES, AS ;
BISHOP, J ;
MANN, GJ ;
RAGHAVAN, D .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (01) :97-100
[6]  
DEPAUW M, 1984, CANC CLIN TRIALS, P64
[7]   EFFECTS OF RECOMBINANT LEUKOCYTE INTERFERON (RIFN-ALPHA-A) ON TUMOR-GROWTH AND IMMUNE-RESPONSES IN PATIENTS WITH METASTATIC MELANOMA [J].
HERSEY, P ;
HASIC, E ;
MACDONALD, M ;
EDWARDS, A ;
SPURLING, A ;
COATES, AS ;
MILTON, GW ;
MCCARTHY, WH .
BRITISH JOURNAL OF CANCER, 1985, 51 (06) :815-826
[8]  
MALDEN LT, 1984, CANCER TREAT REP, V68, P1045
[9]   DESIGN OF FORMS FOR CLINICAL-TRIALS .3. [J].
WRIGHT, P ;
HAYBITTLE, J .
BRITISH MEDICAL JOURNAL, 1979, 2 (6191) :650-651